Actavis Group is pleased to announce that Clamelle Azithromycin 500mg Tablets and Clamelle Chlamydia Test Kits are now available for pharmacy distribution in the UK.
Tag: Actavis
Actavis Group announces business alliance and joint venture in with a Japanese generic pharmaceutical producer
Actavis announced a preliminary agreement with ASKA Pharmaceutical concerning the establishment of a joint company: Actavis ASKA Co., Ltd. – planning to enter the Japanese
R&D Labs in Florida division of Actavis open
New analytical and R&D laboratories to expand the research and development efforts for controlled release and other technically difficult generic pharmaceutical products opened in Actavis
Actavis formally launched in France
Actavis in France was formally launched on 23rd October at a one-day conference held at the Centre Étoile-Saint Honoré, close to the Champs Elysées in
Distribution agreement signed Actavis and J&M Pharma Co. Ltd in South Korea
Actavis, the international generic pharmaceutical company, has entered into an exclusive distribution agreement, for a number of generic products, with J&M Pharma, Co Ltd, a
Actavis constructing new pharmaceutical plants in India
Breaking the ground for a new solid oral dosage plant at Actavis’ current SOD site in Alathur, India. Gudbjorg Edda Eggertsdottir, deputy CEO and G.
Icelandic economic crisis does not affect Actavis
Generic pharmaceutical company Actavis has said that its operations will not be impacted by the current financial turmoil in Iceland. Actavis has released a statement
Actavis receives US approval for generic breast cancer drug
Actavis’ generic breast cancer drug, Epirubicin Hydrochloride Injection, has been approved for sale in the US by the Food & Drug Administration (FDA). Epirubicin Hydrochloride
Actavis and Medis represented at CPhI
Actavis Group employees from diverse departments from all over the world will be present at this year’s annual CPhI conference, held in Frankfurt, Germany, 30
Actavis gets approval for generic Wellbutrin in the United States
Generic drugs company Actavis has received approval from the FDA to market Bupropion Hydrochloride extended-release tablets (XL) 300mg in the US. Actavis, a leading generic
Actavis announces senior appointments
Following Robert Wessman’s departure as CEO, a number of changes in senior management have taken place at the generic pharmaceuticals manufacturer. Actavis Group, the international
